Evidence map›Paper›PMID 38960040›Full record

ArticleThe Journal of biological chemistry2024

Histone H3K18 & H3K23 acetylation directs establishment of MLL-mediated H3K4 methylation.

Geoffrey C Fox, Karl F Poncha, B Rutledge Smith, Lara N van der Maas, Nathaniel N Robbins, Bria Graham, Jill M Dowen, Brian D Strahl, Nicolas L Young, Kanishk Jain

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Capillary Electrophoresis-Mass Spectrometry for Top-Down Proteomics.Annual review of analytical chemistry (Palo Alto, Calif.) · 2025
    Review
  13. Article
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Geoffrey C FoxCurriculum in Genetics and Molecular Biology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Karl F PonchaVerna & Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas, USA.
B Rutledge SmithDepartment of Biochemistry and Biophysics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Lara N van der MaasDepartment of Biochemistry and Biophysics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Nathaniel N RobbinsEpiCypher, Inc, Durham, North Carolina, USA.
Bria GrahamEpiCypher, Inc, Durham, North Carolina, USA.
Jill M DowenDepartment of Biochemistry and Biophysics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Integrative Program for Biological and Genome Sciences, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Brian D StrahlCurriculum in Genetics and Molecular Biology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Department of Biochemistry and Biophysics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Electronic address: brian_strahl@med.unc.edu.
Nicolas L YoungVerna & Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas, USA. Electronic address: nicolas.young@bcm.edu.
Kanishk JainDepartment of Biochemistry and Biophysics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Electronic address: kjain@umn.edu.

Funding

TMEM106b as a lysosomal adaptor to influence brain aging and tau pathogenesisP01AG066606 · NIA · BAYLOR COLLEGE OF MEDICINE · PI JANKOWSKY, JOANNA L · 2021 to 2025
$13.5M
Mechanisms of chromatin and transcriptional regulationR35GM126900 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Brian D Strahl · 2018 to 2026
$5.5M
NRSA in GeneticsT32GM135128 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Daniel J McKay, JEFF J. SEKELSKY · 2020 to 2026
$5.1M
METABOLIC REGULATION IN LEUKEMIA-INITIATING CELLSR01CA193235 · NCI · BAYLOR COLLEGE OF MEDICINE · PI NAKADA, DAISUKE · 2015 to 2024
$4.6M
Neutron encoded activity based probesR01GM139295 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI YOUNG, DAMIAN WINSTON, YOUNG, NICOLAS L · 2020 to 2024
$2.2M
Causes and consequences of differential APP processing in inhibitory and excitatory neuronsR01AG085751 · NIA · WASHINGTON UNIVERSITY · PI JOANNA L JANKOWSKY · 2024 to 2026
$2.0M
Regulation of chromosome structure and gene expression by architectural proteinsR35GM124764 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DOWEN, JILL · 2017 to 2021
$2.0M
Cancer Epigenetics Training GrantT32CA217824 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WEISSMAN, BERNARD E. · 2017 to 2021
$1.8M
Chromatin dysregulation in neurodevelopmental disordersR01NS136375 · NINDS · DUKE UNIVERSITY · PI Anne Elizabeth West · 2024 to 2026
$1.7M
Developmental control of chromatin states in cancerR01CA276663 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Ian J Davis · 2023 to 2026
$1.7M
The role of genome folding in regulating gene expression and chromatin stateR35GM152103 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Jill Dowen · 2024 to 2026
$1.3M
Lysosomal NADPH metabolism regulates proteostasis, aging and tauopathyR01AG074540 · NIA · BAYLOR COLLEGE OF MEDICINE · PI DANG, WEIWEI · 2024 to 2025
$1.0M
NCI NIH HHS F32 CA139893NCI NIH HHS R01 CA193235NCI NIH HHS R01 CA276663NCI NIH HHS T32 CA217824NIA NIH HHS P01 AG066606NIA NIH HHS R01 AG074540NIA NIH HHS R01 AG085751NIGMS NIH HHS R01 GM139295NIGMS NIH HHS R35 GM124764NIGMS NIH HHS R35 GM126900NIGMS NIH HHS R35 GM152103NIGMS NIH HHS T32 GM135128NINDS NIH HHS R01 NS136375
6 · The paper itself

Abstract

In an unmodified state, positively charged histone N-terminal tails engage nucleosomal DNA in a manner which restricts access to not only the underlying DNA but also key tail residues subject to binding and/or modification. Charge-neutralizing modifications, such as histone acetylation, serve to disrupt this DNA-tail interaction, facilitating access to such residues. We previously showed that a polyacetylation-mediated chromatin "switch" governs the read-write capability of H3K4me3 by the MLL1 methyltransferase complex. Here, we discern the relative contributions of site-specific acetylation states along the H3 tail and extend our interrogation to other chromatin modifiers. We show that the contributions of H3 tail acetylation to H3K4 methylation by MLL1 are highly variable, with H3K18 and H3K23 acetylation exhibiting robust stimulatory effects and that this extends to the related H3K4 methyltransferase complex, MLL4. We show that H3K4me1 and H3K4me3 are found preferentially co-enriched with H3 N-terminal tail proteoforms bearing dual H3K18 and H3K23 acetylation (H3{K18acK23ac}). We further show that this effect is specific to H3K4 methylation, while methyltransferases targeting other H3 tail residues (H3K9, H3K27, & H3K36), a methyltransferase targeting the nucleosome core (H3K79), and a kinase targeting a residue directly adjacent to H3K4 (H3T3) are insensitive to tail acetylation. Together, these findings indicate a unique and robust stimulation of H3K4 methylation by H3K18 and H3K23 acetylation and provide key insight into why H3K4 methylation is often associated with histone acetylation in the context of active gene expression.

Indexed as

Histone-Lysine N-MethyltransferaseHistonesMyeloid-Lymphoid Leukemia ProteinAcetylationHumansMethylationNucleosomesProtein Processing, Post-Translationalhistone H3 trimethyl Lys4Histone-Lysine N-MethyltransferaseHistonesKMT2A protein, humanMLL4 protein, humanMyeloid-Lymphoid Leukemia ProteinNucleosomeschromatinepigeneticshistone acetylationhistone methylationnucleosome

Identifiers

PMID38960040
PMCPMC11338103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.